ResveraCel features nicotinamide riboside with a supporting cast of three complementary ingredients that support your body’s natural aging process and cellular metabolism.*Aging is a fact for every baby boomer and Gen-X’er. Although no supplement truly has “anti-aging” properties, ResveraCel comes close because it supports cellular repair, up-regulates the sirtuin proteins, enhances NAD+ production, and benefits the cellular energy production that takes place in the mitochondria – thus supporting the process of healthy aging.*Adding ResveraCel to your daily supplement regimen can make a positive impact on aging and support good health as you get older.*Benefits of Thorne’s ResveraCel: Supports healthy cellular aging* Natural activator of the sirtuin proteins, an important class of protein enzymes that act as cellular switches to up-regulate numerous positive functions associated with aging* Helps clean the body of old cells, by assisting with the elimination of aging cells (inactive, senescent)* Supports optimal mitochondrial number, structure, and function* Supports healthy methylation* Enhances cellular energy production* Promotes healthy metabolism as you age* Benefits healthy blood sugar and insulin sensitivity* Supports fat metabolism in the liver* Suggested Use:Take 2 capsules one to two times daily or as recommended by your health professional.Serving Size: Two CapsulesAmount Per ServingNicotinamide Riboside Hydrogen Malate ... 415mgQuercetin Phytosome ... 250mg((Sophora japonica) extract (flower) / Phospholipid complex from Sunflower)Trans-Resveratrol ... 150mgBetaine Anhydrous ... 85mg(Trimethylglycine)Other Ingredients: Hypromellose (derived from cellulose) Capsule, Leucine, Calcium Laurate, Microcrystalline Cellulose.Gluten Free, Dairy Free, Soy Free ALLERGY WARNINGThis product is contraindicated in an individual with a history of hypersensitivity to any of its ingredients.PREGNANCYIf pregnant, consult your health professional before using this product.INTERACTIONSThere are no known adverse interactions or contraindications at publication date.
